Cargando…

Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization

OBJECTIVE: Transarterial chemoembolization (TACE) is recommended to treat intermediate/advanced stage of hepatocellular carcinoma (HCC). However, the overall survival among initially TACE‐treated patients varies significantly. The clinical characterization of long‐term survival following TACE remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhen‐Xin, Jian, Zhi‐Wei, Wu, Xi‐Wen, Wang, Jun‐Cheng, Peng, Jing‐Yuan, Lao, Xiang‐Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718579/ https://www.ncbi.nlm.nih.gov/pubmed/31313476 http://dx.doi.org/10.1002/cam4.2380

Ejemplares similares

Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization
por: Chen, Zhen-Xin, et al.
Publicado: (2019)

Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization
por: Zhou, Zhong-Guo, et al.
Publicado: (2015)

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable Progression
por: Ren, Yanqiao, et al.
Publicado: (2022)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Chen, Shuling, et al.
Publicado: (2019)

Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
por: Meng, Xiao-Chun, et al.
Publicado: (2018)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2021)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres
por: Albrecht, Katharina Carolin, et al.
Publicado: (2020)

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma
por: He, MinKe, et al.
Publicado: (2019)

Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
por: Kong, Jie-Yu, et al.
Publicado: (2018)

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
por: Kohla, Mohamed A S, et al.
Publicado: (2015)

Identification of a subpopulation of long-term tumor-initiating cells in colon cancer
por: Peng, Linglong, et al.
Publicado: (2020)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2020)

Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2021)

Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Park, Chan, et al.
Publicado: (2021)

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
por: Labeur, Tim A., et al.
Publicado: (2019)

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
por: Kang, Ja Young, et al.
Publicado: (2010)

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
por: Li, Zheng, et al.
Publicado: (2021)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Association of Serum MicroRNA Expression in Hepatocellular Carcinomas Treated with Transarterial Chemoembolization and Patient Survival
por: Liu, Mei, et al.
Publicado: (2014)

Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Zhang, Jin-Xing, et al.
Publicado: (2022)

Correction: Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization
por: Chen, Ke-Li, et al.
Publicado: (2021)

Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article
por: Hu, Hao, et al.
Publicado: (2016)

Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
por: Ji, Suk Kyeong, et al.
Publicado: (2008)

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy
por: Narita, Shintaro, et al.
Publicado: (2019)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure
por: Xiang, Xiao, et al.
Publicado: (2017)

Diffusion Kurtosis Imaging for Assessing the Therapeutic Response of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Yuan, Zhen-Guo, et al.
Publicado: (2020)

A hypoxia-related prognostic model predicts overall survival and treatment response in hepatocellular carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2022)

Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis
por: Qi, Xingshun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_abseejiv2b42de8jc9mcq1ej17